Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Title Grant Type Focus Area Country Application Due Date Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)Release Date:Education Oncology All Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology All The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)Release Date:Education Hospital All Biosimilars in Hematologic Malignancies & Supportive CareRelease Date:Education Oncology All Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast CancerRelease Date:Education Oncology USA Advances in Atopic Dermatitis for Advanced PractitionersRelease Date:Education Inflammation & Immunology USA 2020 RD US- Next Generation PET Imaging for ATTR-CMResearch Rare Disease USA Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant ProgramRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence TreatmentEducation Internal Medicine China, Malaysia, Taiwan, Thailand 4th Quality Improvement initiatives optimizing AF and VTE management in CanadaQuality Improvement Internal Medicine Canada 2021 Rheumatology Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA